Patents by Inventor Hui Zu

Hui Zu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid Pharmaceutical Formulations for Treating Endometriosis, Uterine Fibroids, Polycystic Ovary Syndrome or Adenomyosis
    Publication number: 20250213486
    Abstract: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.
    Type: Application
    Filed: July 31, 2024
    Publication date: July 3, 2025
    Applicants: AbbVie Inc., Neurocrine Biosciences, Inc.
    Inventors: Yihong Qiu, Yuchuan Gong, Alexander Ruggles, Jared A. Baird, Hui Zu, Gregory A. McClelland, Anna V. Stepanenko
  • Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
    Patent number: 12083227
    Abstract: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: September 10, 2024
    Assignees: AbbVie Inc., Neurocrine Biosciences, Inc.
    Inventors: Yihong Qiu, Yuchuan Gong, Alexander Ruggles, Jared A. Baird, Hui Zu, Gregory A. McClelland, Anna V. Stepanenko
  • Solid Pharmaceutical Formulations for Treating Endometriosis, Uterine Fibroids, Polycystic Ovary Syndrome or Adenomyosis
    Publication number: 20190054027
    Abstract: The present disclosure relates to pharmaceutical compositions comprising a gonadotropin-releasing hormone (GnRH) antagonist and methods of preparing and using such compositions. The disclosure also relates to methods of facilitating release of a GnRH antagonist from a pharmaceutical composition.
    Type: Application
    Filed: August 20, 2018
    Publication date: February 21, 2019
    Applicant: AbbVie Inc.
    Inventors: Yihong Qiu, Yuchuan Gong, Alexander Ruggles, Jared A. Baird, Kristof Chwalisz, Charlotte D. Owens, James W. Thomas, Jane Castelli-Haley, Keith Gordon, Michael C. Snabes, Ahmed M. Soliman, Oscar Antunez Flores, Rita Jain, Juki Wing-Keung Ng, Janine D. North, Hannah Palac, Paul M. Peloso, Laura A. Williams, Hui Zu, Yuerong Hu